Hematopoietic Stem Cell TransplantationUnrelated DonorsBone Marrow TransplantationGraft vs Host DiseaseHistocompatibility TestingTransplantation, HomologousTransplantation ConditioningHematopoietic Stem CellsTransplantation, AutologousStem Cell TransplantationBone MarrowBone Marrow CellsTissue DonorsHematologic NeoplasmsWhole-Body IrradiationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationStem CellsGraft SurvivalLiver TransplantationLeukemiaBusulfanHistocompatibilityTreatment OutcomeHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationRetrospective StudiesCombined Modality TherapyKidney TransplantationImmunosuppressive AgentsRemission InductionHematopoietic Stem Cell MobilizationTransplantation, IsogeneicCyclophosphamideGraft vs Leukemia EffectAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsMice, Inbred C57BLBone and BonesChimerismHLA AntigensCell DifferentiationHematologic DiseasesTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSevere Combined ImmunodeficiencySurvival AnalysisBone Marrow PurgingGraft RejectionMultiple MyelomaGraft vs Tumor EffectSurvival RateColony-Forming Units AssayLymphocyte TransfusionCell TransplantationLymphocyte DepletionDisease-Free SurvivalMesenchymal Stem Cell TransplantationFlow CytometryMelphalanAcute DiseaseT-LymphocytesImmunosuppressionCell LineageLymphoma, Non-HodgkinHeart TransplantationBone Marrow DiseasesLeukemia, MyeloidGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsSiblingsRadiation ChimeraLiving DonorsAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesVidarabineAntilymphocyte SerumLung TransplantationOrgan TransplantationCells, CulturedSalvage TherapyFetal BloodCyclosporineStem Cell NicheCell SeparationCytarabineOpportunistic InfectionsEmbryonic Stem CellsPrognosisLeukocyte TransfusionTransplantationAdult Stem CellsImmunocompromised Host